Starfill Deep Plus

Starfill fillers are manufactured utilizing “Zero Endotoxin and BDDE Entire Process” (ZEEP) technology, which ensures minimal endotoxin and residual BDDE levels. The product possesses a high degree of HA cross-linking and exceptional viscoelasticity and cohesiveness parameters. Low amounts of toxins and cross-linking agents maintain the product’s excellent safety and minimize the possibility of post-injection edema, allergic reactions, and other adverse effects. The uniform particle size of the gel assists to the even distribution of the filler during injection and the improvement of its cosmetic effect. Due to the presence of lidocaine, the process is non-painful.

Strengths of StarFill:

• the series contains products varying in the gel particle size and HA cross-linking rate depending on the scope of use endotoxin level is below 0.1 EU/ml
• no residual BDDE even distribution of the gel during injection due to uniform particle size high viscoelasticity and cohesiveness result in longer aesthetic effect duration
• proven effectiveness as demonstrated by the Wrinkle Severity Rating Scale (WSRS) results of the assessment of wrinkle improvement on week 8, 16, and 24 after the injection procedure
• StarFill Deep Plus Lidocaine is used for correction of moderately pronounced and deep facial lines and wrinkles. The filler is injected into the mid and deep dermis.

Scope of StarFill Deep Plus Lidocaine:

• nasolabial folds
• forehead “worry” and glabellar “frown” lines
• chin crease
• perioral wrinkles (marionette lines, smoker’s lines, mouth frown)
• lip contouring and augmentation
• The aesthetic effect lasts from 9 to 15 months.
• Product composition: Cross-linked sodium hyaluronate 24 mg/ml, Lidocaine hydrochloride 3 mg/ml, PBS

StarFill Deep Plus Lidocaine

• 1 syringe × 1.1 ml, 2 needles per pack
• Needle size: 27G